BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang J, Tseng J, Yu G, Luo Y, Huang CF, Hong Y, Chuang T. Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases. Pharmaceutics 2022;14:423. [DOI: 10.3390/pharmaceutics14020423] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Verma SK, Mahajan P, Singh NK, Gupta A, Aggarwal R, Rappuoli R, Johri AK. New-age vaccine adjuvants, their development, and future perspective. Front Immunol 2023;14:1043109. [PMID: 36911719 DOI: 10.3389/fimmu.2023.1043109] [Reference Citation Analysis]
2 Bhoge PR, Mardhekar S, Toraskar S, Subramani B, Kikkeri R. Pairing Nanoparticles Geometry with TLR Agonists to Modulate Immune Responses for Vaccine Development. ACS Appl Bio Mater 2022;5:5675-81. [PMID: 36375049 DOI: 10.1021/acsabm.2c00716] [Reference Citation Analysis]
3 Mishra R, Sharma S, Arora N. TLR-5 ligand conjugated with Per a 10 and T cell peptides potentiates Treg/Th1 response through PI3K/mTOR axis. International Immunopharmacology 2022;113:109389. [DOI: 10.1016/j.intimp.2022.109389] [Reference Citation Analysis]
4 Archana Gopalakrishnan, Katharina Richard, Rezwanul Wahid, Regina Harley, Marcelo B. Sztein, Lynn D. Hawkins, Stefanie N. Vogel. E6020, a TLR4 Agonist Adjuvant, Enhances both Antibody Titers and Isotype Switching in Response to Immunization with Hapten-Protein Antigens and Is Diminished in Mice with TLR4-signaling Insufficiency. J Immunol 2022;209. [PMID: 36426935 DOI: 10.4049/jimmunol.2200495] [Reference Citation Analysis]
5 Aiello A, Ligotti ME, Garnica M, Accardi G, Calabrò A, Pojero F, Arasanz H, Bocanegra A, Blanco E, Chocarro L, Echaide M, Fernandez-rubio L, Ramos P, Piñeiro-hermida S, Kochan G, Zareian N, Farzaneh F, Escors D, Caruso C, Candore G. How Can We Improve Vaccination Response in Old People? Part I: Targeting Immunosenescence of Innate Immunity Cells. IJMS 2022;23:9880. [DOI: 10.3390/ijms23179880] [Reference Citation Analysis]
6 Atapour A, Vosough P, Jafari S, Sarab GA. A multi-epitope vaccine designed against blood-stage of malaria: an immunoinformatic and structural approach. Sci Rep 2022;12:11683. [PMID: 35804032 DOI: 10.1038/s41598-022-15956-3] [Reference Citation Analysis]